Publication | Open Access
MG1113, a specific anti–tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia
24
Citations
18
References
2020
Year
These results indicate that subcutaneous administration of MG1113 neutralizes the function of TFPI and regulates bleeding in individuals with hemophilia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1